Corbus Pharmaceuticals Holdings Inc (CRBP)
42.92
-0.85
(-1.94%)
USD |
NASDAQ |
May 10, 16:00
42.01
-0.91
(-2.12%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2021 | 0.239 |
| June 30, 2021 | 0.2401 |
| March 31, 2021 | 0.2033 |
| December 31, 2020 | 0.4139 |
| September 30, 2020 | 0.611 |
| June 30, 2020 | 0.0023 |
| March 31, 2020 | 0.0191 |
| December 31, 2019 | 0.1222 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0021 |
| March 31, 2019 | 0.0058 |
| December 31, 2018 | 0.0143 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0015 |
| March 31, 2018 | 0.0032 |
| December 31, 2017 | 0.0058 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.001 |
| March 31, 2017 | 0.0036 |
| December 31, 2016 | 0.0305 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0013 |
| March 31, 2016 | 0.0145 |
| December 31, 2015 | 0.018 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2019
0.611
Maximum
Sep 2020
0.1853
Average
0.1628
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 28.27M |
| Total Liabilities (Quarterly) | 35.18M |
| Shareholders Equity (Quarterly) | -6.905M |